Datameds Ai revenue was $8.02M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $1.8M, up 14.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MEDS annual revenue was $23.3M, with 28.7% growth year-over-year.
MEDS past revenue growth
How has MEDS's revenue growth performed historically?
On Aug 18, 2026, Datameds Ai (NASDAQ: MEDS) reported Q2 2026 revenue of $1.78 million up 77.15% year over year. In the same quarter last year, Datameds Ai's revenue was $7.79 million.
What was Datameds Ai's revenue in 2025?
Datameds Ai's annual revenue for the twelve months ending Dec 31, 2025 was $23.34 million, a 28.73% increase year over year.
How much does Datameds Ai make in a day?
Based on Datameds Ai annual revenue for the past three years, MEDS makes an average of $68,173.00 per day.
What was Datameds Ai's annual revenue growth in the past year?
As of Q3 2026, Datameds Ai's revenue has grown -78.16% year over year. This is 114.75 percentage points lower than the US Pharmaceutical Retailers industry revenue growth rate of 36.59%. Datameds Ai's revenue in the past year totaled $8.02 million.
How much does Datameds Ai make in a year?
Datameds Ai's revenue by year for the past three years is:
Datameds Ai's revenue for the twelve months ending Dec 31, 2025 was $23.34 million, a 28.73% increase year over year.
Datameds Ai's annual revenue for Dec 31, 2024 was $18.13 million, a 45.37% decrease from 2023.
Datameds Ai's annual revenue for 2023 was $33.18 million, a 4.06% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.